• Product Spotlight: After Recurrent Pregnancy Loss, What Can Genetic Testing Tell You?

    Christina Ren

    We hear from board-certified genetic counselor Christina Ren about the genes standard testing never looks at after recurrent pregnancy loss, and what a new at-home panel can add.

    Reticular Infertility & Pregnancy Loss Panel

    If you’ve had more than one loss, you may already have had chromosome testing, a karyotype or carrier screening, and still no answer. Here is what those tests leave out, and what a newer test – the Infertility & Pregnancy Loss Panel – which was until recently available only through research studies, can add.

    Reticular product card

    Infertility & Pregnancy Loss Panel

    750+ reproductive genes ยท At-home saliva kit

    One partner: US$250 Both partners: US$500

    Report and genetic counseling included

    View panel options

    Why do so many pregnancy losses stay unexplained?

    When losses are tested, and most aren’t, about half trace back to a random chromosomal change in that pregnancy. The other half stay unexplained, and much of the reason is what the standard workup checks: chromosomes, not the individual genes reproduction depends on.

    How is this different from the testing I’ve already had?

    Each test you may have had checks something different:

    • Pregnancy-tissue testing: the chromosomes of one pregnancy.
    • Parental karyotype: the number and structure of your chromosomes.
    • Carrier screening: whether a child could inherit certain conditions.

    None of them reads the genes that make reproduction work: the ones that build the egg and sperm, allow fertilization and carry an embryo through its first weeks. That is where early losses happen, and none of these tests look there. A reproductive-gene panel reads exactly those genes in you and your partner. Reticular’s Infertility & Pregnancy Loss Panel is that test, alongside the others, not in place of them.

    Why hasn’t my doctor offered this?

    Until recently it existed only in research. Single-gene causes of loss have been described for years, but finding them meant enrolling in a genome-sequencing study at an academic center: in a 2025 study from UCSF, Stanford and other centers, sequencing 118 families with unexplained, chromosomally normal recurrent loss found a likely single-gene cause in about 1 in 4 (Aminbeidokhti et al., 2025). Outside of academic settings, none of these couples would have been offered testing for it. Reticular’s panel takes the same approach, in a saliva kit you can order yourself, with a genetic counselor to review the results.

    Who is it for?

    Anyone with a question standard testing hasn’t answered, including:

    • two or more early losses
    • a loss where the pregnancy tissue tested chromosomally normal
    • eggs that don’t fertilize, or embryos that stop growing, in IVF
    • unexplained infertility
    • a molar pregnancy

    You don’t need to be doing IVF. You can test before your next pregnancy rather than after another loss. The panel covers conception through the first trimester; later losses have a different workup.

    How does it work?

    Choose one partner or both. Reticular ships the kit, each person returns a saliva sample, and the lab screens more than 750 genes, from egg and sperm development through fertilization, embryo growth and pregnancy support. You get a plain-language report and a session with a genetic counselor. Testing both partners gives the fullest picture, since some findings matter only when you both carry a change in the same gene.

    The panel includes a report and a conversation with a genetic counselor.

    What will the report show?

    For each partner, either no reportable finding or a short list: the gene, what it does, how strong the evidence is, and how it is inherited. Look at a sample couple’s report before you order; it is illustrative, not a real patient.

    Illustrative layoutโ€”not an actual result. Your report depends on your results and history.

    What can I do with the results?

    A finding gives your care team something specific to plan around: closer monitoring in your next pregnancy, such as earlier ultrasounds; OB or reproductive endocrinologist recommendations tailored to the gene; or IVF, where embryos can be screened for the variant and embryos without it prioritized for transfer. Reticular’s Embryo Core does that screening from your embryos’ existing PGT-A data, no new biopsy, for $750. A carrier finding may mean testing your partner or family. Your care team decides what changes.

    What can’t it tell me?

    No reportable finding means nothing was found under the panel’s methods and evidence standards, not that all genetic causes are ruled out. It does not diagnose a condition, recommend treatment, or predict whether your next pregnancy will succeed.

    What does it cost?

    $250 for one partner or $500 for both, report and genetic counseling included; Affirm from $23 a month. Order from the product page, or book a free call with a genetic counselor there first.

    Wondering whether a gene could explain your losses?

    Whether you’ve had two losses with no explanation, a loss that tested chromosomally normal, embryos that keep arresting, or you’re planning your next pregnancy after loss, Reticular’s at-home panel reads the reproductive genes standard testing leaves out, and a genetic counselor goes through the results with you.

    At a glance

    • Test type: At-home saliva kit; 750+ genes tied to fertility, early embryo development and pregnancy loss.
    • Who: One partner or both. No IVF or clinic visit required.
    • Price: $250 (one partner) or $500 (both), genetic counseling included. Affirm from $23/month.
    • Results: Plain-language report of each finding’s gene, evidence and inheritance, reviewed with you by a genetic counselor.
    • What it isn’t: A diagnosis, a treatment plan or a prediction for your next pregnancy. Discuss results with your care team.

    View panel options

    Christina Ren is a genetic counselor at Reticular, where she helps people understand reproductive genetic testing, interpret their reports, and prepare questions for their care teams.

    References

    Aminbeidokhti M, et al.; Rajkovic A. Genetic Variants in Recurrent Euploid Pregnancy Loss. medRxiv (preprint), 2025. doi:10.1101/2025.10.01.25335660

    Practice Committee of the American Society for Reproductive Medicine. Recurrent pregnancy loss: a committee opinion. Fertil Steril. 2026;125:1023โ€“1041.

    ESHRE Guideline Group on RPL. Recurrent Pregnancy Loss: Guideline of the European Society of Human Reproduction and Embryology (2022 update). ESHRE, 2023.

    Share this blog post

    Facebook
    Twitter
    LinkedIn

    Read our latest issue

    Support Female Health & Fertility

    We hope you enjoyed this article. To help us to create more content like this, please consider visiting our Shop.

    Read more from our blog

    Get your FREE Copy of Female Health & Fertility Magazine

    *You’ll also receive our free newsletter!
    EM Logos FINAL_Text Image Logo_White
    08.24_FHF_Issue11_cover_F